Research programme: immunological disorder therapeutics - Schrodinger/Bristol Myers Squibb
Latest Information Update: 04 Jan 2021
At a glance
- Originator Schrodinger
- Developer Bristol-Myers Squibb; Schrodinger
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Immunological disorders